Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Co TSMC Ltd | 6,668 |
| 2 | International Business Machines Corp | 2,518 |
| 3 | Samsung Electronics Co Ltd | 2,150 |
| 4 | GlobalFoundries Inc | 1,692 |
| 5 | Sony Group Corp | 1,318 |
| 6 | LG Chem Ltd | 1,274 |
| 7 | Micron Technology Inc | 1,243 |
| 8 | TDK Corp | 1,066 |
| 9 | Semiconductor Energy Laboratory Co Ltd | 945 |
| 10 | General Electric Co | 936 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | H01L | Semiconductor devices | 28,050 |
| 2 | H10D | 27,331 | |
| 3 | H10P | 14,996 | |
| 4 | H10W | 10,394 | |
| 5 | H10B | 9,685 |
| 6 | Y02E | Climate change mitigation: energy | 6,946 |
| 7 | C23C | 6,637 | |
| 8 | B82Y | Nanotechnology | 5,309 |
| 9 | C04B | 5,040 | |
| 10 | H10K | Organic semiconductors / OLEDs | 4,800 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Lanthanum hafnium oxide dielectrics | 2007 | Micron Technology Inc | 592 |
| Lanthanide oxide / hafnium oxide dielectric layers | 2007 | Micron Technology Inc | 579 |
| Lanthanide oxide / hafnium oxide dielectric layers | 2007 | Micron Technology Inc | 555 |
| Lanthanide oxide / hafnium oxide dielectrics | 2006 | Micron Technology Inc | 107 |
| Deposition of hafnium oxide and/or zirconium oxide and fabrication of passivated electronic structures | 2006 | GlobalFoundries Inc | 100 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 11 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 6 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Naeemunnisa Mohamed Anesary | Nanobiotix (France) | 4 |
| 2 | Julie Marill | Nanobiotix (France) | 4 |
| 3 | C. Le Péchoux | Institut Gustave Roussy | 3 |
| 4 | Víctor Moreno | Hospital Universitario Fundación Jiménez Díaz | 3 |
| 5 | Sébastien Paris | Nanobiotix (France) | 3 |
| 6 | Thierry de Baère | Institut Gustave Roussy | 3 |
| 7 | Elsa Borghi | Nanobiotix (France) | 3 |
| 8 | Sylvie Bonvalot | Université Paris Sciences et Lettres | 3 |
| 9 | Markus Andreas Schubert | Leibniz Institute for High Performance Microelectronics | 2 |
| 10 | Eduardo Pérez | Leibniz Institute for High Performance Microelectronics | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial | 2019 | 521 | Sarcoma Diagnosis and Treatment |
| Nanoscale Radiotherapy with Hafnium Oxide Nanoparticles | 2012 | 366 | Advanced Radiotherapy Techniques |
| High-Bandwidth Protein Analysis Using Solid-State Nanopores | 2014 | 259 | Microfluidic and Bio-sensing Technologies |
| First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas | 2016 | 240 | Sarcoma Diagnosis and Treatment |
| RRAM-based synapse devices for neuromorphic systems | 2018 | 236 | Advanced Memory and Neural Computing |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of hafnium dioxide?
Which companies hold the most patents involving hafnium dioxide?
What are the main technology areas covered by hafnium dioxide patents?
How has patent activity for hafnium dioxide changed over recent years?
What biomedical applications of hafnium dioxide are represented in the literature?